(Q39669271)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Lead time associated with screening for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Magnus Törnblom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Henry Eriksson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Stefan Franzén

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ove Gustafsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ulf Norming

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jonas Hugosson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

122-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

21 December 2019

cites work

1 reference

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

21 January 2018

1 reference

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

21 January 2018

1 reference

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

21 January 2018

1 reference

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

21 January 2018

1 reference

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

21 January 2018

1 reference

Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials.

21 January 2018

1 reference

Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening

21 January 2018

1 reference

Should we start population screening for prostate cancer? Randomised trials are still needed

21 January 2018

1 reference

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

21 January 2018

1 reference

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

21 January 2018

1 reference

Lead-time in prostate cancer screening (Finland)

21 January 2018

1 reference

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

21 January 2018

1 reference

The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913

21 January 2018

1 reference

Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration

21 January 2018

1 reference

Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14618626%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference